Safety Alerts weekly digest
Important notice: This digest is gathered automatically from official NHS and government sources. It is provided for information and convenience only — always refer to the original source and follow your practice’s own clinical governance procedures. View the full alert list.
Alerts and Recalls for Drugs and Medical Devices - All
- Class 4 Medicines Defect Notification: Fresenius Medical Care Deutschland GmbH, balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis, EL(26)A/24 Original alert (opens in a new tab)
- Field Safety Notices: 27 April to 1 May 2026 Original alert (opens in a new tab)
- Field Safety Notices: 4 to 8 May 2026 Original alert (opens in a new tab)
- Class 4 Medicines Defect Notification: Milpharm Limited, Loperamide hydrochloride 2 mg Orodispersible Tablets, EL(26)A/23 Original alert (opens in a new tab)
PSNC Dispensing & Supply News
- May 2026 Price Concessions 1st Update Original alert (opens in a new tab)
- MHRA Class 4 Medicines Defect Notification: balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis (Fresenius Medical Care Deutschland GmbH) Original alert (opens in a new tab)
- MHRA Drug Safety Update: Finasteride and Dutasteride – updated safety warnings Original alert (opens in a new tab)
- MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd) Original alert (opens in a new tab)
No sources selected.
Get the weekly digest by email is run by the existing Haresign Safety Alerts service: sign up or manage your subscription there
Copy for email
Paste into an email, or use the button to copy it.
Copy for a spreadsheet
Tab-separated: paste into Excel or Google Sheets. Columns: Date, Source, Reference, Details, Link.